Skip to main content
. 2012 Nov 5;2(11):1040–1053. doi: 10.7150/thno.4652

Figure 3.

Figure 3

Optical imaging with 89Zr-bevacizumab-IRDye800CW in a tumor-bearing mouse. Adapted from 76.